Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 01-2003 | 12-2002 | 10-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,890 | -1,890 | -1,420 | -1,420 | -400 |
| Depreciation Amortization | 100 | 100 | 60 | 60 | 30 |
| Other Working Capital | -5 | -5 | 80 | 80 | 30 |
| Other Operating Activity | 45 | 45 | 10 | 10 | 20 |
| Operating Cash Flow | $-1,750 | $-1,750 | $-1,270 | $-1,270 | $-320 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -30 | -30 | -30 | -20 |
| Other Investing Activity | -20 | -20 | -20 | -20 | -10 |
| Investing Cash Flow | $-50 | $-50 | $-50 | $-50 | $-30 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -100 | -100 | -80 | -80 | -50 |
| Financing Cash Flow | $-100 | $-100 | $-80 | $-80 | $-50 |
| Beginning Cash Position | 2,440 | 2,440 | 2,440 | 2,440 | 2,440 |
| End Cash Position | 520 | 520 | 1,030 | 1,030 | 2,020 |
| Net Cash Flow | $-1,910 | $-1,910 | $-1,400 | $-1,400 | $-420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,750 | -1,750 | -1,270 | -1,270 | -320 |
| Free Cash Flow | -1,750 | -1,750 | -1,270 | -1,270 | -320 |